K. Peony Yu

2020

In 2020, K. Peony Yu earned a total compensation of $3.5M as Former Chief Medical Officer at FibroGen, a 40% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$459,000
Option Awards$1,201,950
Salary$612,000
Stock Awards$1,188,450
Other$51,364
Total$3,512,764

Yu received $1.2M in option awards, accounting for 34% of the total pay in 2020.

Yu also received $459K in non-equity incentive plan, $612K in salary, $1.2M in stock awards and $51.4K in other compensation.

Rankings

In 2020, K. Peony Yu's compensation ranked 3,299th out of 13,090 executives tracked by ExecPay. In other words, Yu earned more than 74.8% of executives.

ClassificationRankingPercentile
All
3,299
out of 13,090
75th
Division
Manufacturing
1,280
out of 5,621
77th
Major group
Chemicals And Allied Products
481
out of 2,254
79th
Industry group
Drugs
417
out of 1,954
79th
Industry
Pharmaceutical Preparations
311
out of 1,459
79th

Pay ratio

K. Peony Yu's Pay$3,512,764
Median Employee's Pay$177,952
Pay Ratio

20

to 1

In 2020, the annual total compensation of K. Peony Yu was $3,512,764.

The annual total compensation of the median employee at FibroGen was $177,952.

The ratio of K. Peony Yu's pay to the pay of median employee was therefore 20 to one.

Source: SEC filing on April 13, 2021.

Yu's colleagues

We found seven more compensation records of executives who worked with K. Peony Yu at FibroGen in 2020.

2020

Enrique Conterno

FibroGen

Chief Executive Officer

2020

Thane Wettig

FibroGen

Chief Commercial Officer

2020

Mark Eisner

FibroGen

Chief Medical Officer

2020

Pat Cotroneo

FibroGen

Chief Financial Officer

2020

Elias Kouchakji

FibroGen

Senior Vice President, Clinical Development, Drug Safety, and Pharmacovigilance

2020

Christine Chung

FibroGen

Senior Vice President, China Operations

2020

James Schoeneck

FibroGen

Chief Executive Officer

News

You may also like